Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $47.5B |
| FY2017, ended Dec 31, 2017 | $54.3B |
| FY2018, ended Dec 31, 2018 | $54.1B |
| FY2019, ended Dec 31, 2019 | $67.2B |
| FY2020, ended Dec 31, 2020 | $168B |
| FY2021, ended Dec 31, 2021 | $145B |
| FY2022, ended Dec 31, 2022 | $171B |
| FY2023, ended Dec 31, 2023 | $190B |
| FY2024, ended Dec 31, 2024 | $252B |
| FY2025, ended Dec 31, 2025 | $224B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $180B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $37.5B |
| FY2017, ended Dec 31, 2017 | $40.6B |
| FY2018, ended Dec 31, 2018 | $43.3B |
| FY2019, ended Dec 31, 2019 | $45.0B |
| FY2020, ended Dec 31, 2020 | $68.4B |
| FY2021, ended Dec 31, 2021 | $80.1B |
| FY2022, ended Dec 31, 2022 | $79.6B |
| FY2023, ended Dec 31, 2023 | $78.6B |
| FY2024, ended Dec 31, 2024 | $81.4B |
| FY2025, ended Dec 31, 2025 | $88.3B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $92.2B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.46B | −$1.92B |
| FY2017, ended Dec 31, 2017 | $4.54B | −$1.41B |
| FY2018, ended Dec 31, 2018 | $2.89B | −$1.64B |
| FY2019, ended Dec 31, 2019 | $3.47B | $433M |
| FY2020, ended Dec 31, 2020 | $3.06B | −$2.39B |
| FY2021, ended Dec 31, 2021 | $3.02B | $1.59B |
| FY2022, ended Dec 31, 2022 | $2.59B | $2.81B |
| FY2023, ended Dec 31, 2023 | $8.32B | $8.76B |
| FY2024, ended Dec 31, 2024 | $11.3B | $13.5B |
| FY2025, ended Dec 31, 2025 | $11.0B | $18.0B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $10.6B | $18.4B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $5.50B |
| FY2017, ended Dec 31, 2017 | $1.22B |
| FY2018, ended Dec 31, 2018 | $1.20B |
| FY2019, ended Dec 31, 2019 | $1.53B |
| FY2020, ended Dec 31, 2020 | $10.4B |
| FY2021, ended Dec 31, 2021 | $6.63B |
| FY2022, ended Dec 31, 2022 | $4.51B |
| FY2023, ended Dec 31, 2023 | $5.13B |
| FY2024, ended Dec 31, 2024 | $5.41B |
| FY2025, ended Dec 31, 2025 | $5.60B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.83B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $27.8B |
| FY2017, ended Dec 31, 2017 | $28.3B |
| FY2018, ended Dec 31, 2018 | $13.0B |
| FY2019, ended Dec 31, 2019 | $25.0B |
| FY2020, ended Dec 31, 2020 | $75.7B |
| FY2021, ended Dec 31, 2021 | $77.6B |
| FY2022, ended Dec 31, 2022 | $77.1B |
| FY2023, ended Dec 31, 2023 | $78.6B |
| FY2024, ended Dec 31, 2024 | $82.3B |
| FY2025, ended Dec 31, 2025 | $91.4B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | — |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 29.8% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 827M |
| FY2017, ended Dec 31, 2017 | 854M |
| FY2018, ended Dec 31, 2018 | 850M |
| FY2019, ended Dec 31, 2019 | 857M |
| FY2020, ended Dec 31, 2020 | 1.24B |
| FY2021, ended Dec 31, 2021 | 1.25B |
| FY2022, ended Dec 31, 2022 | 1.22B |
| FY2023, ended Dec 31, 2023 | 1.19B |
| FY2024, ended Dec 31, 2024 | 1.14B |
| FY2025, ended Dec 31, 2025 | 1.10B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 1.07B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash | Used in acquisitions |
|---|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $0 | $235M | — | — |
| FY2017, ended Dec 31, 2017 | $427M | $306M | — | — |
| FY2018, ended Dec 31, 2018 | $1.07B | $424M | $0 | — |
| FY2019, ended Dec 31, 2019 | $0 | $495M | $0 | — |
| FY2020, ended Dec 31, 2020 | $19.5B | $694M | $19.8B | $33.5B |
| FY2021, ended Dec 31, 2021 | $0 | $540M | $0 | — |
| FY2022, ended Dec 31, 2022 | $3.00B | $595M | $0 | — |
| FY2023, ended Dec 31, 2023 | $13.1B | $667M | — | — |
| FY2024, ended Dec 31, 2024 | $11.2B | $649M | — | — |
| FY2025, ended Dec 31, 2025 | $9.97B | $829M | — | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $12.1B | $866M | — | — |
Valuation
At current price- Market Cap
- $158B
- P/E
- 14.9×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 1.7×
- Price / Book
- 2.8×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $92.2B
- Revenue Growth YoY
- 9.7%
- Revenue CAGR 3Y
- 3.5%
- Revenue CAGR 5Y
- 5.2%
- EPS Growth YoY
- −9.7%
- Net Income Growth YoY
- −13.5%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 19.8%
- Net Margin
- 11.5%
- FCF Margin
- 20.0%
- Return on Equity
- 18.0%
Earnings
Trailing 12 months- Net Income
- $10.6B
- EPS (diluted)
- $9.56
- EBITDA
- $32.7B
- Operating Income
- $18.3B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $2.83B
- Total Debt
- —. Short- and long-term borrowings, excluding leases
- Net Cash
- —. Cash − total debt
- Total Assets
- $214B
- Total Liabilities
- $157B
- Shareholders' Equity
- $56.3B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $28.8B
- Capital Expenditure
- $10.4B
- Free Cash Flow
- $18.4B
Dividends and risk
Last 12 months- Dividend Yield
- 2.8%
- Dividend / Share
- $4.08
- Beta (5Y)
- 0.33
Every ratio is calculated from the company’s reported figures.